| dc.contributor.author | Perez-Caballero, Laura | |
| dc.contributor.author | Pérez, V. | |
| dc.contributor.author | Berrocoso Domínguez, Esther María | |
| dc.contributor.other | Neurociencias | es_ES |
| dc.contributor.other | Psicología | es_ES |
| dc.date.accessioned | 2025-07-11T09:11:22Z | |
| dc.date.available | 2025-07-11T09:11:22Z | |
| dc.date.issued | 2020 | |
| dc.identifier.issn | 1746-045X | |
| dc.identifier.issn | 1746-0441 | |
| dc.identifier.uri | http://hdl.handle.net/10498/36694 | |
| dc.format | application/pdf | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Taylor and Francis | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.source | Expert Opinion on Drug Discovery | es_ES |
| dc.title | What ketamine can teach us about the opioid system in depression? | es_ES |
| dc.type | editorial | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.identifier.doi | 10.1080/17460441.2020.1781812 | |
| dc.type.hasVersion | VoR | es_ES |